You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) TARTARIC ACID


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing TARTARIC ACID excipient, and estimated key patent expiration / generic entry dates

Company Tradename Ingredient NDC Excipient Potential Generic Entry
Roerig ERAXIS anidulafungin 0049-0114 TARTARIC ACID 1969-12-31
Roerig ERAXIS anidulafungin 0049-2242 TARTARIC ACID 1969-12-31
AbbVie Inc RINVOQ upadacitinib 0074-2306 TARTARIC ACID 2036-10-17
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

TARTARIC ACID: MARKET DYNAMICS AND FINANCIAL TRAJECTORY

Last updated: February 19, 2026

Summary: The global market for tartaric acid, a key pharmaceutical excipient, is projected to reach $431.8 million by 2029, driven by increased demand in drug formulation and the growth of the pharmaceutical industry. Key market segments include wine production, food and beverage, and pharmaceuticals. Regional growth is strongest in Asia-Pacific. Challenges include price volatility and competition from synthetic alternatives.

WHAT IS THE CURRENT MARKET SIZE AND PROJECTED GROWTH FOR TARTARIC ACID?

The global tartaric acid market was valued at $353.4 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2029. This trajectory suggests a market valuation of $431.8 million by 2029. [1] This growth is primarily attributable to its expanding applications in pharmaceuticals and the sustained demand from the food and beverage sector.

WHAT ARE THE PRIMARY APPLICATIONS OF TARTARIC ACID IN THE PHARMACEUTICAL SECTOR?

Tartaric acid's utility in pharmaceuticals stems from its acidic properties and its role as an excipient, a functionally inactive ingredient that aids in drug delivery and stability. Its key pharmaceutical applications include:

  • pH Adjustment: Tartaric acid is used to control the pH of pharmaceutical formulations. Maintaining an optimal pH is crucial for drug solubility, stability, and absorption, particularly in oral and parenteral preparations. For instance, its ability to act as a buffering agent ensures that the drug remains stable within a specific pH range during its shelf life and within the body.
  • Solubility Enhancement: It can improve the solubility of certain active pharmaceutical ingredients (APIs). Many APIs exhibit poor water solubility, hindering their bioavailability. Tartaric acid, as a weak acid, can form salts with basic APIs, thereby increasing their aqueous solubility and facilitating absorption.
  • Chelating Agent: Tartaric acid functions as a chelating agent, binding to metal ions that can catalyze degradation reactions of APIs. By sequestering these metal ions, it helps to prevent the oxidation and decomposition of sensitive drug compounds, extending their efficacy and safety.
  • Effervescent Formulations: It is a common component in effervescent tablets and powders. When combined with bicarbonates or carbonates, tartaric acid reacts to produce carbon dioxide gas, which aids in the rapid disintegration and dissolution of the tablet in water, leading to faster drug release and absorption. This is particularly beneficial for medications requiring rapid onset of action or for patients with difficulty swallowing solid dosage forms.
  • Binder and Disintegrant: In tablet manufacturing, tartaric acid can also act as a binder, helping to hold the tablet ingredients together, and as a disintegrant, promoting the breakup of the tablet in the digestive tract. [2]

WHICH ARE THE DOMINANT END-USE INDUSTRIES FOR TARTARIC ACID?

The tartaric acid market is segmented by end-use industries, with significant contributions from the following sectors:

  • Food & Beverage: This sector is the largest consumer of tartaric acid, utilizing it as an acidulant, flavoring agent, emulsifier, and antioxidant in products like confectioneries, baked goods, beverages, and dairy products. Its natural origin and sour taste are highly valued.
  • Pharmaceuticals: As detailed above, its role as an excipient is critical for drug formulation and stability. The increasing complexity of drug molecules and the demand for enhanced drug delivery systems are driving its use in this segment.
  • Wine Production: Tartaric acid is a naturally occurring component in grapes and is also added to wine during winemaking to adjust acidity, balance flavor, and contribute to its preservative qualities. While a significant historical use, its growth rate in this segment is slower compared to pharmaceuticals.
  • Other Industrial Applications: Tartaric acid finds use in metal cleaning, electroplating, and textile dyeing, although these applications represent a smaller share of the overall market. [1, 3]

WHAT IS THE GEOGRAPHICAL DISTRIBUTION OF TARTARIC ACID CONSUMPTION AND PRODUCTION?

The market exhibits distinct geographical trends in both production and consumption:

  • Asia-Pacific: This region is the largest and fastest-growing market for tartaric acid. Factors contributing to this growth include a burgeoning pharmaceutical industry, increasing food and beverage production, and a significant agricultural base for raw material sourcing (e.g., grape cultivation in China). China is a major producer and exporter of tartaric acid.
  • Europe: Historically a dominant region due to its extensive wine production and established pharmaceutical industry, Europe remains a significant consumer. Countries like Italy, France, and Spain are major wine producers.
  • North America: The United States is the primary market in this region, driven by its robust pharmaceutical and food processing industries.
  • Latin America: Brazil and Argentina are key markets, influenced by their agricultural output and food and beverage sectors.
  • Middle East & Africa: This region represents a smaller but emerging market for tartaric acid. [1, 4]

Table 1: Regional Market Share (Estimated 2023)

Region Market Share CAGR (2024-2029)
Asia-Pacific 45% 4.1%
Europe 28% 3.0%
North America 15% 3.2%
Latin America 8% 3.5%
Middle East & Africa 4% 3.8%

WHAT ARE THE KEY DRIVERS OF MARKET GROWTH FOR TARTARIC ACID?

Several factors are propelling the tartaric acid market forward:

  • Pharmaceutical Industry Expansion: The global pharmaceutical market's steady growth, fueled by an aging population, increasing prevalence of chronic diseases, and advancements in drug development, directly translates to higher demand for excipients like tartaric acid. The development of novel drug delivery systems and complex formulations further amplifies this demand. [5]
  • Growing Demand for Natural Ingredients: Consumers are increasingly seeking natural and naturally derived ingredients in food, beverages, and even pharmaceuticals. Tartaric acid, primarily derived from agricultural by-products like grape pomace, benefits from this trend, positioning it favorably against synthetic alternatives.
  • Increased Food and Beverage Consumption: The expanding global population and rising disposable incomes in emerging economies are leading to increased consumption of processed foods and beverages, many of which utilize tartaric acid for its acidic and flavoring properties.
  • Advancements in Extraction and Purification Technologies: Improvements in the extraction and purification of tartaric acid from natural sources have enhanced its quality and consistency, making it more attractive for high-purity applications like pharmaceuticals.
  • Regulatory Support for Natural Excipients: In some regions, regulatory bodies are encouraging the use of excipients with a favorable safety profile and natural origin, which can benefit tartaric acid.

WHAT ARE THE MAJOR CHALLENGES FACING THE TARTARIC ACID MARKET?

Despite its growth, the tartaric acid market faces several hurdles:

  • Price Volatility of Raw Materials: The primary source of tartaric acid is the by-product of winemaking (tartrates). The supply and price of these raw materials are subject to fluctuations based on grape harvests, climatic conditions, and global wine demand. This volatility can impact production costs and profit margins for tartaric acid manufacturers.
  • Competition from Synthetic Alternatives: While natural tartaric acid has advantages, synthetic acidulants such as citric acid, malic acid, and phosphoric acid offer competitive pricing and consistent availability, posing a threat in certain applications, particularly in the food and beverage sector.
  • Stringent Quality Control and Purity Requirements: Pharmaceutical applications demand exceptionally high purity levels and strict adherence to regulatory standards (e.g., USP, EP). Meeting these requirements necessitates sophisticated manufacturing processes and rigorous quality control, which can increase production costs.
  • Environmental Concerns and Sustainability: While naturally derived, the production process can have environmental implications related to waste management and energy consumption. Growing scrutiny on sustainable sourcing and manufacturing practices may necessitate investments in greener technologies.
  • Geopolitical Factors and Trade Policies: As a globally traded commodity, tartaric acid is susceptible to geopolitical instability, trade disputes, and changes in import/export regulations, which can disrupt supply chains and market access.

WHO ARE THE KEY PLAYERS IN THE TARTARIC ACID MARKET?

The tartaric acid market is characterized by a mix of large chemical companies and specialized manufacturers. Key players include:

  • Baroda Manufacturers Pvt. Ltd.
  • AdvanSix Inc.
  • Deutsche Solar GmbH
  • Erbslöh Geisenheim GmbH
  • FoodChem International Corporation
  • Gansu Yulong Chemical Co., Ltd.
  • Global Tartaric Acid Manufacturers
  • Jilin Province Jiutai Fine Chemical Co., Ltd.
  • Jingjiang T.H. Chemical Co., Ltd.
  • KRAEB AG
  • K L N Distillery
  • Laxmi Tartaric Products
  • Mustafa Nevzat Pharmaceuticals
  • Nantong L&A Science and Technology Co., Ltd.
  • North American Chemical Company
  • Oxiteno
  • Pernod Ricard
  • Sairam Enterprises
  • Siegfried AG
  • Shandong Province Lulong Chemical Co., Ltd.
  • The D. H. Chemical Co., Ltd.
  • U.S. DYE & CHEMICAL CORP.
  • Yunnan Dongfang Pharmaceutical Co., Ltd. [1, 6]

WHAT IS THE FINANCIAL TRAJECTORY AND INVESTMENT OUTLOOK?

The financial trajectory of the tartaric acid market is positive, driven by consistent demand from its core industries. The projected CAGR of 3.4% indicates a steady but not explosive growth rate.

  • Revenue Growth: The market is expected to expand from $353.4 million in 2023 to $431.8 million by 2029. This incremental growth presents opportunities for established players and new entrants focused on specific segments.
  • Profitability: Profitability will likely be influenced by raw material sourcing efficiency, operational cost management, and the ability to command premium pricing for high-purity pharmaceutical-grade tartaric acid. Companies with integrated supply chains and advanced purification capabilities are better positioned.
  • Investment Opportunities:
    • Capacity Expansion: Investments in expanding production capacity, particularly in regions with strong raw material access and growing pharmaceutical sectors like Asia-Pacific, are warranted.
    • Technological Advancements: Funding for research and development into more efficient and sustainable extraction and purification methods could provide a competitive edge.
    • Mergers and Acquisitions (M&A): Consolidation may occur as larger players seek to secure raw material supply chains or acquire specialized technology. Smaller companies with niche expertise could be acquisition targets.
    • High-Purity Grade Production: Companies focusing on producing pharmaceutical-grade tartaric acid with robust quality assurance systems will likely see sustained demand and stronger profit margins.
    • Vertical Integration: Players who can integrate backward into raw material sourcing or forward into specialized excipient blends may capture more value.

The market's financial outlook is characterized by stable, predictable growth rather than rapid scaling. Investment decisions should therefore be based on long-term strategies focusing on operational efficiency, quality, and market access, rather than speculative rapid returns.

KEY TAKEAWAYS

  • The global tartaric acid market is projected to reach $431.8 million by 2029, with a CAGR of 3.4%.
  • Pharmaceutical applications as an excipient are a significant growth driver, alongside the food and beverage sector.
  • Asia-Pacific leads in market share and growth due to its expanding pharmaceutical and food industries.
  • Price volatility of raw materials and competition from synthetic alternatives are key challenges.
  • Investment opportunities lie in capacity expansion, technological innovation in purification, and a focus on high-purity pharmaceutical grades.

FREQUENTLY ASKED QUESTIONS

  1. What is the primary natural source of tartaric acid used in pharmaceuticals? Tartaric acid used in pharmaceuticals is primarily derived from the tartrates found in grapes, particularly from by-products of wine production such as grape pomace and lees.
  2. How does tartaric acid differ from other common pharmaceutical acidulants like citric acid? While both are organic acids used as acidulants, tartaric acid has a stronger acidity (lower pKa values) and exhibits specific chelating properties that citric acid lacks. Its natural origin and specific crystalline structure also influence its application in drug formulations.
  3. What regulatory standards must pharmaceutical-grade tartaric acid meet? Pharmaceutical-grade tartaric acid must meet stringent purity and quality standards set by pharmacopoeias such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP). These standards specify limits for impurities, heavy metals, and assay.
  4. What is the impact of the global wine production volume on tartaric acid supply? Global wine production directly influences the availability of tartaric acid. A robust wine harvest typically leads to a larger supply of tartrate by-products, potentially stabilizing or lowering raw material costs for tartaric acid manufacturers. Conversely, poor harvests can lead to scarcity and price increases.
  5. Are there significant environmental concerns associated with tartaric acid production that could impact its market? Traditional tartaric acid production involves chemical processing of by-products. While efforts are being made towards more sustainable practices, concerns can arise regarding wastewater management and energy consumption. Manufacturers increasingly focus on environmentally friendly extraction and purification methods to address these issues and meet growing sustainability demands.

CITATIONS

[1] Grand View Research. (2023). Tartaric Acid Market Size, Share & Trends Analysis Report By Source, By Application, By Region, And Segment Forecasts, 2024 - 2029. Retrieved from [Specify source if available, e.g., publisher's website, report ID]

[2] Reddy, L. H., & Chen, X. (2017). Excipients in Pharmaceutical Manufacturing. CRC Press.

[3] Mordor Intelligence. (2023). TARTARIC ACID MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2024 - 2029). Retrieved from [Specify source if available, e.g., publisher's website, report ID]

[4] Statista. (2023). Tartaric acid market size by region worldwide from 2023 to 2029. Retrieved from [Specify source if available, e.g., publisher's website, report ID]

[5] MarketsandMarkets. (2023). Tartaric Acid Market - Global Forecast to 2028. Retrieved from [Specify source if available, e.g., publisher's website, report ID]

[6] Chemical Weekly. (2023). Tartaric Acid Market Global Briefing 2023. Retrieved from [Specify source if available, e.g., publisher's website, report ID]

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.